US Stock MarketDetailed Quotes

ANIK Anika Therapeutics

Watchlist
  • 14.850
  • +0.390+2.70%
Close May 2 16:00 ET
  • 14.850
  • 0.0000.00%
Post 16:01 ET
212.97MMarket Cap-3.88P/E (TTM)

Anika Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-0.73%119.91M
55.50%-1.29M
-6.54%38.75M
-5.37%41.92M
6.85%40.52M
6.12%120.79M
-4.02%-2.9M
2.98%41.47M
11.71%44.3M
3.35%37.92M
Operating revenue
-0.73%119.91M
55.50%-1.29M
-6.54%38.75M
-5.37%41.92M
6.85%40.52M
6.12%120.79M
-4.02%-2.9M
2.98%41.47M
11.71%44.3M
3.35%37.92M
Cost of revenue
14.76%43.91M
-175.08%-23.86M
125.85%37.31M
-5.05%14.56M
5.40%15.9M
-5.78%38.26M
-32.15%-8.67M
-5.51%16.52M
3.62%15.33M
1.29%15.08M
Gross profit
-7.92%76M
290.87%22.57M
-94.23%1.44M
-5.55%27.37M
7.81%24.63M
12.72%82.53M
52.93%5.77M
9.50%24.94M
16.53%28.97M
4.77%22.84M
Operating expense
-0.72%81.1M
88.63%-2.15M
-19.20%26.36M
-16.56%27.2M
-16.12%29.69M
17.45%81.69M
-49.90%-18.93M
14.14%32.62M
15.44%32.6M
39.59%35.4M
Selling and administrative expenses
-7.29%55.56M
68.63%-4.89M
-23.02%19.11M
-16.39%19.81M
-20.26%21.53M
16.97%59.93M
-48.22%-15.59M
16.69%24.83M
11.38%23.69M
40.60%27M
Research and development costs
17.37%25.54M
181.93%2.74M
-7.02%7.24M
-17.01%7.4M
-2.81%8.16M
18.79%21.76M
-58.24%-3.34M
6.71%7.79M
27.80%8.91M
36.43%8.4M
Operating profit
-704.38%-5.1M
0.06%24.72M
-224.68%-24.92M
104.43%161K
59.67%-5.06M
-77.00%844K
50.59%24.7M
-32.36%-7.67M
-7.39%-3.63M
-253.21%-12.55M
Net non-operating interest income expense
1.08%2.34M
28.94%744K
-36.06%406K
6.06%595K
9.83%592K
253.52%2.31M
109.06%577K
45.64%635K
484.38%561K
450.00%539K
Non-operating interest income
----
----
-36.06%406K
----
----
----
----
--635K
----
----
Total other finance cost
-1.08%-2.34M
----
----
-6.06%-595K
-9.83%-592K
-253.52%-2.31M
----
----
-484.38%-561K
-450.00%-539K
Other net income (expense)
-3.1M
Special income (charges)
----
----
---3.1M
----
----
----
----
--0
----
----
-Less:Impairment of capital assets
----
----
--3.1M
----
----
----
----
--0
----
----
Income before tax
-187.58%-2.76M
12.99%28.56M
-292.26%-27.61M
124.63%756K
62.79%-4.47M
-27.01%3.16M
51.56%25.28M
-31.28%-7.04M
6.54%-3.07M
-224.00%-12.01M
Income tax
-8.05%6.06M
-68.29%2.87M
598.27%2.31M
356.53%844K
102.58%43K
210.50%6.6M
99.89%9.05M
60.99%-463K
25.57%-329K
-114.71%-1.66M
Net income
31.79%-56.39M
65.29%-21.87M
-354.96%-29.92M
96.79%-88K
56.39%-4.51M
-456.34%-82.67M
-1,183.62%-63M
-57.51%-6.58M
3.59%-2.74M
-252.88%-10.35M
Net income continuous Operations
-156.70%-8.83M
58.32%25.69M
-354.96%-29.92M
96.79%-88K
56.39%-4.51M
-256.32%-3.44M
33.55%16.23M
-57.51%-6.58M
3.59%-2.74M
-252.88%-10.35M
Net income discontinuous operations
39.97%-47.56M
----
----
----
----
-364.44%-79.23M
----
----
----
----
Minority interest income
Net income attributable to the parent company
31.79%-56.39M
65.29%-21.87M
-354.96%-29.92M
96.79%-88K
56.39%-4.51M
-456.34%-82.67M
-1,183.62%-63M
-57.51%-6.58M
3.59%-2.74M
-252.88%-10.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
31.79%-56.39M
65.29%-21.87M
-354.96%-29.92M
96.79%-88K
56.39%-4.51M
-456.34%-82.67M
-1,183.62%-63M
-57.51%-6.58M
3.59%-2.74M
-252.88%-10.35M
Basic earnings per share
32.09%-3.83
65.12%-1.5
-351.11%-2.03
94.74%-0.01
56.34%-0.31
-452.94%-5.64
-1,164.71%-4.3
-55.17%-0.45
5.00%-0.19
-255.00%-0.71
Diluted earnings per share
32.09%-3.83
65.12%-1.5
-351.11%-2.03
94.74%-0.01
56.34%-0.31
-452.94%-5.64
-1,164.71%-4.3
-55.17%-0.45
5.00%-0.19
-255.00%-0.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -0.73%119.91M55.50%-1.29M-6.54%38.75M-5.37%41.92M6.85%40.52M6.12%120.79M-4.02%-2.9M2.98%41.47M11.71%44.3M3.35%37.92M
Operating revenue -0.73%119.91M55.50%-1.29M-6.54%38.75M-5.37%41.92M6.85%40.52M6.12%120.79M-4.02%-2.9M2.98%41.47M11.71%44.3M3.35%37.92M
Cost of revenue 14.76%43.91M-175.08%-23.86M125.85%37.31M-5.05%14.56M5.40%15.9M-5.78%38.26M-32.15%-8.67M-5.51%16.52M3.62%15.33M1.29%15.08M
Gross profit -7.92%76M290.87%22.57M-94.23%1.44M-5.55%27.37M7.81%24.63M12.72%82.53M52.93%5.77M9.50%24.94M16.53%28.97M4.77%22.84M
Operating expense -0.72%81.1M88.63%-2.15M-19.20%26.36M-16.56%27.2M-16.12%29.69M17.45%81.69M-49.90%-18.93M14.14%32.62M15.44%32.6M39.59%35.4M
Selling and administrative expenses -7.29%55.56M68.63%-4.89M-23.02%19.11M-16.39%19.81M-20.26%21.53M16.97%59.93M-48.22%-15.59M16.69%24.83M11.38%23.69M40.60%27M
Research and development costs 17.37%25.54M181.93%2.74M-7.02%7.24M-17.01%7.4M-2.81%8.16M18.79%21.76M-58.24%-3.34M6.71%7.79M27.80%8.91M36.43%8.4M
Operating profit -704.38%-5.1M0.06%24.72M-224.68%-24.92M104.43%161K59.67%-5.06M-77.00%844K50.59%24.7M-32.36%-7.67M-7.39%-3.63M-253.21%-12.55M
Net non-operating interest income expense 1.08%2.34M28.94%744K-36.06%406K6.06%595K9.83%592K253.52%2.31M109.06%577K45.64%635K484.38%561K450.00%539K
Non-operating interest income ---------36.06%406K------------------635K--------
Total other finance cost -1.08%-2.34M---------6.06%-595K-9.83%-592K-253.52%-2.31M---------484.38%-561K-450.00%-539K
Other net income (expense) -3.1M
Special income (charges) -----------3.1M------------------0--------
-Less:Impairment of capital assets ----------3.1M------------------0--------
Income before tax -187.58%-2.76M12.99%28.56M-292.26%-27.61M124.63%756K62.79%-4.47M-27.01%3.16M51.56%25.28M-31.28%-7.04M6.54%-3.07M-224.00%-12.01M
Income tax -8.05%6.06M-68.29%2.87M598.27%2.31M356.53%844K102.58%43K210.50%6.6M99.89%9.05M60.99%-463K25.57%-329K-114.71%-1.66M
Net income 31.79%-56.39M65.29%-21.87M-354.96%-29.92M96.79%-88K56.39%-4.51M-456.34%-82.67M-1,183.62%-63M-57.51%-6.58M3.59%-2.74M-252.88%-10.35M
Net income continuous Operations -156.70%-8.83M58.32%25.69M-354.96%-29.92M96.79%-88K56.39%-4.51M-256.32%-3.44M33.55%16.23M-57.51%-6.58M3.59%-2.74M-252.88%-10.35M
Net income discontinuous operations 39.97%-47.56M-----------------364.44%-79.23M----------------
Minority interest income
Net income attributable to the parent company 31.79%-56.39M65.29%-21.87M-354.96%-29.92M96.79%-88K56.39%-4.51M-456.34%-82.67M-1,183.62%-63M-57.51%-6.58M3.59%-2.74M-252.88%-10.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 31.79%-56.39M65.29%-21.87M-354.96%-29.92M96.79%-88K56.39%-4.51M-456.34%-82.67M-1,183.62%-63M-57.51%-6.58M3.59%-2.74M-252.88%-10.35M
Basic earnings per share 32.09%-3.8365.12%-1.5-351.11%-2.0394.74%-0.0156.34%-0.31-452.94%-5.64-1,164.71%-4.3-55.17%-0.455.00%-0.19-255.00%-0.71
Diluted earnings per share 32.09%-3.8365.12%-1.5-351.11%-2.0394.74%-0.0156.34%-0.31-452.94%-5.64-1,164.71%-4.3-55.17%-0.455.00%-0.19-255.00%-0.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More